Treating HSV and CMV reactivations in critically ill patients who are not immunocompromised: pro

被引：22
|
作者：
Forel, Jean-Marie [1 ,2 ]
Martin-Loeches, Ignacio [3 ]
Luyt, Charles-Edouard [4 ]
机构：
[1] Hop Nord Marseille, Assistance Publ Hop Marseille, F-13015 Marseille, France
[2] Aix Marseille Univ, UMR CNRS 7278, Fac Med, URMITE, F-13005 Marseille, France
[3] St James Univ Hosp, MICRO, Trinity Ctr Hlth Sci, Dublin 8, Ireland
[4] Univ Paris 06, Hop Pitie Salpetriere, Assistance Publ Hop Paris, Serv Reanimat,ICAN,Inst Cardiometab & Nutr, F-75651 Paris 13, France
来源：
INTENSIVE CARE MEDICINE | 2014年 / 40卷 / 12期
关键词：
HERPES-SIMPLEX-VIRUS; CYTOMEGALOVIRUS REACTIVATION; INFECTION; IMMUNOSUPPRESSION; ACYCLOVIR; SURVIVAL; SEPSIS;
D O I：
10.1007/s00134-014-3445-y
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1945 / 1949
页数：5
相关论文
共 41 条
  • [1] Treating HSV and CMV reactivations in critically ill patients who are not immunocompromised: con
    Chanques, G.
    Jaber, S.
    INTENSIVE CARE MEDICINE, 2014, 40 (12) : 1950 - 1953
  • [2] Treatment of HSV and CMV Reactivations in the Intensive Care Unit: Who and When?
    Luyt, C-E
    Hekimian, G.
    Brechot, N.
    MEDECINE INTENSIVE REANIMATION, 2019, 28 (03): : 232 - 238
  • [3] Optimizing Antiviral Dosing for HSV and CMV Treatment in Immunocompromised Patients
    Huntjens, Daan W.
    Dijkstra, Jacob A. A.
    Verwiel, Lisanne N. N.
    Slijkhuis, Mirjam
    Elbers, Paul
    Welkers, Matthijs R. A.
    Veldkamp, Agnes I. I.
    Kuijvenhoven, Marianne A. A.
    de Leeuw, David C. C.
    Abdullah-Koolmees, Heshu
    Kuipers, Maria T. T.
    Bartelink, Imke H. H.
    PHARMACEUTICS, 2023, 15 (01)
  • [4] Diagnostic accuracy of procalcitonin in critically ill immunocompromised patients
    Bele, Nicolas
    Darmon, Michael
    Coquet, Isaline
    Feugeas, Jean-Paul
    Legriel, Stephane
    Adaoui, Nadir
    Schlemmer, Benoit
    Azoulay, Elie
    BMC INFECTIOUS DISEASES, 2011, 11
  • [5] Clinical features and outcome of influenza pneumonia in critically-ill immunocompromised patients
    Raymond, Matthieu
    Martin, Maelle
    Lamouche-Wilquin, Pauline
    Blonz, Gauthier
    Decamps, Paul
    Agbakou, Maite
    Desmedt, Luc
    Reignier, Jean
    Lascarrou, Jean-Baptiste
    Canet, Emmanuel
    MEDICINE, 2022, 101 (49) : E32245
  • [6] Treating critically ill patients with probiotics: Beneficial or dangerous?
    Jacobi, Christoph A.
    Schulz, Christian
    Malfertheiner, Peter
    GUT PATHOGENS, 2011, 3
  • [7] HSV-1 reactivation is associated with an increased risk of mortality and pneumonia in critically ill COVID-19 patients
    Meyer, Antoine
    Buetti, Niccolo
    Houhou-Fidouh, Nadhira
    Patrier, Juliette
    Abdel-Nabey, Moustafa
    Jaquet, Pierre
    Presente, Simona
    Girard, Tiphaine
    Sayagh, Faiza
    Ruckly, Stephane
    Wicky, Paul-Henri
    de Montmollin, Etienne
    Bouadma, Lila
    Sonneville, Romain
    Descamps, Diane
    Timsit, Jean-Francois
    CRITICAL CARE, 2021, 25 (01)
  • [8] Histone-Associated Thrombocytopenia in Patients Who Are Critically Ill
    Alhamdi, Yasir
    Abrams, Simon T.
    Lane, Steven
    Wang, Guozheng
    Toh, Cheng-Hock
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (08): : 817 - 819
  • [9] Outcomes of Critically Ill Patients Who Received Cardiopulmonary Resuscitation
    Tian, Jianmin
    Kaufman, David A.
    Zarich, Stuart
    Chan, Paul S.
    Ong, Philip
    Amoateng-Adjepong, Yaw
    Manthous, Constantine A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 182 (04) : 501 - 506
  • [10] Prospective flow cytometry analysis of leucocyte subsets in critically ill patients who develop sepsis: a pilot study
    Layios, Nathalie
    Gosset, Christian
    Maes, Nathalie
    Delierneux, Celine
    Hego, Alexandre
    Huart, Justine
    Lecut, Christelle
    Damas, Pierre
    Oury, Cecile
    Gothot, Andre
    INFECTION, 2023, 51 (05) : 1305 - 1317
12345